Clinical Trials
6
Active:0
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 4:3
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (50.0%)Not Applicable
2 (33.3%)Phase 1
1 (16.7%)The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy
Not Applicable
Completed
- Conditions
- Seroma
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2018-08-27
- Lead Sponsor
- Memorial Health University Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03647930
- Locations
- 🇺🇸
Memorial Health University Medical Center, Savannah, Georgia, United States
Correlation of CO2 Measured by Blood Gas vs Transcutaneous Monitor
Not Applicable
- Conditions
- Respiratory Complication
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2017-08-31
- Lead Sponsor
- Memorial Health University Medical Center
- Target Recruit Count
- 266
- Registration Number
- NCT03268395
- Locations
- 🇺🇸
Memorial University Medical Center, Savannah, Georgia, United States
Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy
Phase 4
- Conditions
- Sentinel Lymph Node BiopsyBreast Cancer
- Interventions
- Drug: Tc 99m filtered sulfur colloid
- First Posted Date
- 2017-06-27
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- Memorial Health University Medical Center
- Target Recruit Count
- 86
- Registration Number
- NCT03199560
- Locations
- 🇺🇸
Memorial Health University Medical Center, Savannah, Georgia, United States
Hernia Surgery Urinary Retention
- First Posted Date
- 2017-01-20
- Last Posted Date
- 2018-03-23
- Lead Sponsor
- Memorial Health University Medical Center
- Target Recruit Count
- 140
- Registration Number
- NCT03027115
- Locations
- 🇺🇸
Memorial Health University Medical Center, Savannah, Georgia, United States
The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
Phase 1
- Conditions
- Hypertension, Resistant to Conventional Therapy
- Interventions
- First Posted Date
- 2015-12-07
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- Memorial Health University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02623036
- Locations
- 🇺🇸
Memorial Family Medicine Center, Savannah, Georgia, United States
- Prev
- 1
- 2
- Next
News
No news found